AIM-listed medical group LiDCO announced US-based healthcare firm NantHealth has developed a communications link between LiDCO's blood analysis monitors and its DeviceConX system.
NantHealth's software, DeviceConx, collects and transmits data from medical devices into an electronic record for docto
LONDON (Alliance News) - LiDCO Group PLC said Wednesday said US-based NantHealth has successfully completed development of a proprietary communications link between LiDCO monitors and its own DeviceConX system. NantHealth's DeviceConX is a software solution that collects and transmits data
LONDON (Alliance News) - LiDCO Group PLC Tuesday said a recent study published in the Journal of American Medical Association found that perioperative hemodynamic intervention is associated with a reduced complication rate and length of stay in hospital after surgery. A test was conducted i
LONDON (Alliance News) - LiDCO Group PLC Thursday noted a study that it said showed that an enhanced recovery after surgery programme using its haemodynamic monitors reduced length of hospital stay and incidences of urinary tract infections. The study, by the Enhanced Recovery Study Group a
LONDON (Alliance News) - LiDCO PLC Tuesday expressed confidence for 2014 after it swung to a pretax profit for 2013, as revenue was boosted by strong growth from its UK business. LiDCO produces cardiac monitoring equipment and disposables. LiDCO posted a pretax profit of GBP217,000, s
LONDON (Alliance News) - LiDCO Group PLC said Monday that it will be launching a new version of its LiDCOrapidv2 software at the International Symposium on Intensive Care and Emergency Medicine in Brussels. The conference, organised by the department of Intensive Care Emergency Medicine of
(Correcting direction of FTSE 250 index.) LONDON (Alliance News) - Housebuilders lead a surprisingly upbeat UK equities market Monday, occupying six of the top ten spaces in the FTSE 350, buoyed by an extension to the UK government's Help to Buy scheme.
LONDON (Alliance News) - Housebuilders lead a surprisingly upbeat UK equities market Monday, occupying six of the top ten spaces in the FTSE 350, buoyed by an extension to the UK government's Help to Buy scheme.
Chancellor George Osborne confirmed that the government's flagship Help
An independent medical study proving the cost-effectiveness of monitoring bloodflow during surgery has been welcomed by AIM-listed LiDCO, whose equipment was used for the trials.
Published data examining the cost effectiveness of post-operative goal-directed therapy (GDT), a surgical intervention t
LONDON (Alliance News) - LiDCO Group PLC said Wednesday that a study into the cost-effectiveness of Postoperative Goal-Directed Therapy proved that this type of care was both cost and clinically effective, supporting the use of its LiDCOplus monitoring equipment. The LiDCOplus monitor provi